Literature DB >> 17353906

Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins.

K R Ostler1, E M Davis, S L Payne, B B Gosalia, J Expósito-Céspedes, M M Le Beau, L A Godley.   

Abstract

Cancer cells display an altered distribution of DNA methylation relative to normal cells. Certain tumor suppressor gene promoters are hypermethylated and transcriptionally inactivated, whereas repetitive DNA is hypomethylated and transcriptionally active. Little is understood about how the abnormal DNA methylation patterns of cancer cells are established and maintained. Here, we identify over 20 DNMT3B transcripts from many cancer cell lines and primary acute leukemia cells that contain aberrant splicing at the 5' end of the gene, encoding truncated proteins lacking the C-terminal catalytic domain. Many of these aberrant transcripts retain intron sequences. Although the aberrant transcripts represent a minority of the DNMT3B transcripts present, Western blot analysis demonstrates truncated DNMT3B isoforms in the nuclear protein extracts of cancer cells. To test if expression of a truncated DNMT3B protein could alter the DNA methylation patterns within cells, we expressed DNMT3B7, the most frequently expressed aberrant transcript, in 293 cells. DNMT3B7-expressing 293 cells have altered gene expression as identified by microarray analysis. Some of these changes in gene expression correlate with altered DNA methylation of corresponding CpG islands. These results suggest that truncated DNMT3B proteins could play a role in the abnormal distribution of DNA methylation found in cancer cells.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17353906      PMCID: PMC2435620          DOI: 10.1038/sj.onc.1210351

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  52 in total

1.  Histone H1 depletion in mammals alters global chromatin structure but causes specific changes in gene regulation.

Authors:  Yuhong Fan; Tatiana Nikitina; Jie Zhao; Tomara J Fleury; Riddhi Bhattacharyya; Eric E Bouhassira; Arnold Stein; Christopher L Woodcock; Arthur I Skoultchi
Journal:  Cell       Date:  2005-12-29       Impact factor: 41.582

Review 2.  E-cadherin in gastric cancer.

Authors:  Annie On On Chan
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

3.  Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients.

Authors:  Anni Aggerholm; Mette S Holm; Per Guldberg; Lene H Olesen; Peter Hokland
Journal:  Eur J Haematol       Date:  2006-01       Impact factor: 2.997

4.  A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer.

Authors:  Luo Wang; Jie Wang; Shiyong Sun; Marivonne Rodriguez; Ping Yue; Se Jin Jang; Li Mao
Journal:  Int J Oncol       Date:  2006-07       Impact factor: 5.650

5.  Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis.

Authors:  Yasuhiro Yamada; Laurie Jackson-Grusby; Heinz Linhart; Alex Meissner; Amir Eden; Haijiang Lin; Rudolf Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-08       Impact factor: 11.205

6.  Roles for Dnmt3b in mammalian development: a mouse model for the ICF syndrome.

Authors:  Yoshihide Ueda; Masaki Okano; Christine Williams; Taiping Chen; Katia Georgopoulos; En Li
Journal:  Development       Date:  2006-03       Impact factor: 6.868

7.  Suppression of intestinal neoplasia by deletion of Dnmt3b.

Authors:  Haijiang Lin; Yasuhiro Yamada; Suzanne Nguyen; Heinz Linhart; Laurie Jackson-Grusby; Alexander Meissner; Konstantinos Meletis; Grace Lo; Rudolf Jaenisch
Journal:  Mol Cell Biol       Date:  2006-04       Impact factor: 4.272

8.  Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene.

Authors:  Dirk O Watermann; Yesheng Tang; Axel Zur Hausen; Markus Jäger; Stefan Stamm; Elmar Stickeler
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

Review 9.  Cadherins and catenins in breast cancer.

Authors:  Pamela Cowin; Tracey M Rowlands; Sarah J Hatsell
Journal:  Curr Opin Cell Biol       Date:  2005-10       Impact factor: 8.382

10.  Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors.

Authors:  M Ehrlich; C B Woods; M C Yu; L Dubeau; F Yang; M Campan; D J Weisenberger; Ti Long; B Youn; E S Fiala; P W Laird
Journal:  Oncogene       Date:  2006-04-27       Impact factor: 9.867

View more
  67 in total

1.  Contributions of CTCF and DNA methyltransferases DNMT1 and DNMT3B to Epstein-Barr virus restricted latency.

Authors:  David J Hughes; Elessa M Marendy; Carol A Dickerson; Kristen D Yetming; Clare E Sample; Jeffery T Sample
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis.

Authors:  Mrinal Y Shah; Aparna Vasanthakumar; Natalie Y Barnes; Maria E Figueroa; Anna Kamp; Christopher Hendrick; Kelly R Ostler; Elizabeth M Davis; Shang Lin; John Anastasi; Michelle M Le Beau; Ivan P Moskowitz; Ari Melnick; Peter Pytel; Lucy A Godley
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

3.  DNMT3B interacts with constitutive centromere protein CENP-C to modulate DNA methylation and the histone code at centromeric regions.

Authors:  Suhasni Gopalakrishnan; Beth A Sullivan; Stefania Trazzi; Giuliano Della Valle; Keith D Robertson
Journal:  Hum Mol Genet       Date:  2009-05-29       Impact factor: 6.150

Review 4.  Aberrant RNA splicing and its functional consequences in cancer cells.

Authors:  James D Fackenthal; Lucy A Godley
Journal:  Dis Model Mech       Date:  2008 Jul-Aug       Impact factor: 5.758

5.  Increased expression of androgen receptor coregulator MAGE-11 in prostate cancer by DNA hypomethylation and cyclic AMP.

Authors:  Adam R Karpf; Suxia Bai; Smitha R James; James L Mohler; Elizabeth M Wilson
Journal:  Mol Cancer Res       Date:  2009-04       Impact factor: 5.852

Review 6.  Perspectives and future directions for epigenetics in hematology.

Authors:  Margaret A Goodell; Lucy A Godley
Journal:  Blood       Date:  2013-05-21       Impact factor: 22.113

Review 7.  Molecular epigenetics and genetics in neuro-oncology.

Authors:  Raman P Nagarajan; Joseph F Costello
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 8.  Anti-cancer therapies that utilize cell penetrating peptides.

Authors:  Benjamin G Bitler; Joyce A Schroeder
Journal:  Recent Pat Anticancer Drug Discov       Date:  2010-06       Impact factor: 4.169

9.  DNMT gene expression and methylome in Marek's disease resistant and susceptible chickens prior to and following infection by MDV.

Authors:  Fei Tian; Fei Zhan; Nathan D VanderKraats; Jeffrey F Hiken; John R Edwards; Huanmin Zhang; Keji Zhao; Jiuzhou Song
Journal:  Epigenetics       Date:  2013-03-28       Impact factor: 4.528

10.  Vezf1 regulates genomic DNA methylation through its effects on expression of DNA methyltransferase Dnmt3b.

Authors:  Humaira Gowher; Heidi Stuhlmann; Gary Felsenfeld
Journal:  Genes Dev       Date:  2008-08-01       Impact factor: 11.361

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.